IL153934A0 - 16 alpha-methyl or ethyl substituted estrogens - Google Patents
16 alpha-methyl or ethyl substituted estrogensInfo
- Publication number
- IL153934A0 IL153934A0 IL15393401A IL15393401A IL153934A0 IL 153934 A0 IL153934 A0 IL 153934A0 IL 15393401 A IL15393401 A IL 15393401A IL 15393401 A IL15393401 A IL 15393401A IL 153934 A0 IL153934 A0 IL 153934A0
- Authority
- IL
- Israel
- Prior art keywords
- alpha
- methyl
- ethyl substituted
- estrogens
- substituted estrogens
- Prior art date
Links
- 229940011871 estrogen Drugs 0.000 title 1
- 239000000262 estrogen Substances 0.000 title 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00202697 | 2000-07-28 | ||
| PCT/EP2001/008535 WO2002010188A1 (en) | 2000-07-28 | 2001-07-23 | 16alpha-methyl or ethyl substituted estrogens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL153934A0 true IL153934A0 (en) | 2003-07-31 |
Family
ID=8171866
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15393401A IL153934A0 (en) | 2000-07-28 | 2001-07-23 | 16 alpha-methyl or ethyl substituted estrogens |
| IL153934A IL153934A (en) | 2000-07-28 | 2003-01-14 | Estrogens are converted at position 16 alpha by methyl or ethyl |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL153934A IL153934A (en) | 2000-07-28 | 2003-01-14 | Estrogens are converted at position 16 alpha by methyl or ethyl |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7696190B2 (cs) |
| EP (1) | EP1307471B1 (cs) |
| JP (1) | JP2004505093A (cs) |
| KR (1) | KR20030029640A (cs) |
| CN (1) | CN1220696C (cs) |
| AR (1) | AR029989A1 (cs) |
| AT (1) | ATE294812T1 (cs) |
| AU (2) | AU8201601A (cs) |
| BR (1) | BR0112791A (cs) |
| CA (1) | CA2416311C (cs) |
| CZ (1) | CZ2003270A3 (cs) |
| DE (1) | DE60110606T2 (cs) |
| EC (1) | ECSP034448A (cs) |
| ES (1) | ES2241854T3 (cs) |
| HR (1) | HRP20030060A2 (cs) |
| HU (1) | HUP0301592A2 (cs) |
| IL (2) | IL153934A0 (cs) |
| IS (1) | IS6692A (cs) |
| MX (1) | MXPA03000845A (cs) |
| NO (1) | NO20030419L (cs) |
| PE (1) | PE20020331A1 (cs) |
| PL (1) | PL366235A1 (cs) |
| SK (1) | SK882003A3 (cs) |
| WO (1) | WO2002010188A1 (cs) |
| ZA (1) | ZA200300417B (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003059931A1 (en) * | 2002-01-21 | 2003-07-24 | Akzo Nobel N.V. | PROCESS FOR THE PREPARATION OF 7α-METHYLSTEROIDS |
| DE10213371C1 (de) * | 2002-03-21 | 2003-12-24 | Schering Ag | Verfahren zur Herstellung von 7alpha-Methylsteroiden |
| CN101014610B (zh) * | 2004-09-08 | 2012-08-22 | Msd欧斯股份有限公司 | 具有选择性雌激素活性的15β-取代的类固醇 |
| UA89964C2 (ru) * | 2004-09-08 | 2010-03-25 | Н.В. Органон | 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ |
| CN114409717B (zh) * | 2021-12-17 | 2023-03-17 | 湖南科益新生物医药有限公司 | 替勃龙中间体醚化物和替勃龙的制备方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL226738A (cs) * | 1957-04-11 | |||
| DE1084261B (de) * | 1957-04-11 | 1960-06-30 | Syntex Sa | Verfahren zur Herstellung neuer Cyclopentanophenanthrenderivate |
| US3257429A (en) * | 1957-11-12 | 1966-06-21 | Syntex Corp | 16-methylene derivatives of estrone and estradiol |
| US3007946A (en) * | 1958-11-06 | 1961-11-07 | Searle & Co | 3-alkoxy-16-methylene-1, 3, 5(10)-estratrien-17-ones |
| US3049555A (en) * | 1959-12-22 | 1962-08-14 | Searle & Co | 3-alkoxy-16-methyl-1, 3, 5 (10)-estratrien-17-ones |
| US3092645A (en) * | 1961-12-28 | 1963-06-04 | Searle & Co | Esters of 17alpha-alkynylester-5(10)-ene-3beta, 17beta-diols |
| GB1110792A (en) * | 1964-04-07 | 1968-04-24 | Res Inst Medicine Chem | Novel 5(10)-dehydro-steroids |
| US3299108A (en) * | 1965-10-18 | 1967-01-17 | Searle & Co | 17alpha-alkynyl/alkenyl-13beta-alkyl-11-alkylgona-1, 3, 5 (10)-triene-3, 17beta-diols, ethers and esters thereof and intermediates thereto |
| US3465010A (en) * | 1966-11-22 | 1969-09-02 | Searle & Co | 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof |
| US3377366A (en) * | 1966-12-02 | 1968-04-09 | Searle & Co | 17alpha-alkynyl/alkenyl-11, 13beta-dialkylgon-5(10)-en-3-ones and esters thereof |
| ZA712312B (en) | 1970-04-28 | 1972-01-26 | Ochsner Med Found Alton | 4,14-estradiene compounds |
| US3652606A (en) * | 1970-08-07 | 1972-03-28 | Searle & Co | 3-oxygenated 11beta-methylestr-4-en-17beta-ol and esters thereof |
| US3704253A (en) * | 1970-09-23 | 1972-11-28 | American Home Prod | 13 - polycarbonalkyl - 16 - methylgona-1,3,5(10)-trienes and 13-polycarbonalkyl-16-methylgon - 4 - en-3-ones and intermediates for their production |
| FR2377419A1 (fr) * | 1977-01-13 | 1978-08-11 | Roussel Uclaf | Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament |
| DE2757157C3 (de) | 1977-12-19 | 1980-10-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von 16 a -alkylierten Steroiden |
| AU572589B2 (en) | 1983-12-14 | 1988-05-12 | Upjohn Company, The | 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids |
| US5116830A (en) * | 1984-08-17 | 1992-05-26 | Sri International | Stereoisomerically pure 17α-ethynyl-estra-2-en-17β-ol and the 17β esters thereof, methods of preparation and uses |
| DE3822770A1 (de) * | 1988-07-01 | 1990-01-04 | Schering Ag | 13-alkyl-11ss-phenylgonane |
| ZA94715B (en) | 1993-02-08 | 1994-10-24 | Akzo Nv | Steroids for treating menopausal complaints |
| ES2134313T3 (es) | 1993-03-05 | 1999-10-01 | Akzo Nobel Nv | Utilizacion de derivados de pregnano para el tratamiento de tumores. |
| NZ506115A (en) | 1998-03-09 | 2003-07-25 | Akzo Nobel Nv | Contraceptive kit containing a compound with both estrogenic and progestagenic activity |
| DK1087986T3 (da) * | 1998-06-19 | 2002-06-17 | Akzo Nobel Nv | Testosteronderivat |
| ATE222922T1 (de) | 1998-11-20 | 2002-09-15 | Akzo Nobel Nv | Estrogenische estra-1,3,5(10)-trien verbindungen mit verschiedenen wirkungen auf estrogenrezeptor alpha und beta mit einer unverzweigten kohlenwasserstoffkette von 5-9 kohlenstoffatomen in position 11 |
| TW548277B (en) * | 1999-07-16 | 2003-08-21 | Akzo Nobel Nv | Orally active androgens |
| TR200200575T2 (tr) * | 1999-09-06 | 2002-06-21 | Akzo Nobel N. V. | 11 Konumunda bir hidrokarbon ikame ediciye sahip, aromatik olmayan östrojenik steroidler. |
-
2001
- 2001-07-23 BR BR0112791-8A patent/BR0112791A/pt not_active IP Right Cessation
- 2001-07-23 HU HU0301592A patent/HUP0301592A2/hu unknown
- 2001-07-23 SK SK88-2003A patent/SK882003A3/sk unknown
- 2001-07-23 US US10/343,293 patent/US7696190B2/en not_active Expired - Fee Related
- 2001-07-23 ES ES01960546T patent/ES2241854T3/es not_active Expired - Lifetime
- 2001-07-23 JP JP2002515917A patent/JP2004505093A/ja not_active Withdrawn
- 2001-07-23 IL IL15393401A patent/IL153934A0/xx active IP Right Grant
- 2001-07-23 AT AT01960546T patent/ATE294812T1/de not_active IP Right Cessation
- 2001-07-23 CZ CZ2003270A patent/CZ2003270A3/cs unknown
- 2001-07-23 AU AU8201601A patent/AU8201601A/xx active Pending
- 2001-07-23 KR KR10-2003-7001186A patent/KR20030029640A/ko not_active Withdrawn
- 2001-07-23 PL PL01366235A patent/PL366235A1/xx unknown
- 2001-07-23 CN CNB018133983A patent/CN1220696C/zh not_active Expired - Fee Related
- 2001-07-23 AU AU2001282016A patent/AU2001282016B2/en not_active Ceased
- 2001-07-23 MX MXPA03000845A patent/MXPA03000845A/es active IP Right Grant
- 2001-07-23 WO PCT/EP2001/008535 patent/WO2002010188A1/en active IP Right Grant
- 2001-07-23 EP EP01960546A patent/EP1307471B1/en not_active Expired - Lifetime
- 2001-07-23 DE DE60110606T patent/DE60110606T2/de not_active Expired - Lifetime
- 2001-07-23 HR HR20030060A patent/HRP20030060A2/hr not_active Application Discontinuation
- 2001-07-23 CA CA002416311A patent/CA2416311C/en not_active Expired - Fee Related
- 2001-07-25 PE PE2001000751A patent/PE20020331A1/es not_active Application Discontinuation
- 2001-07-26 AR ARP010103558A patent/AR029989A1/es unknown
-
2003
- 2003-01-14 IL IL153934A patent/IL153934A/en not_active IP Right Cessation
- 2003-01-15 ZA ZA200300417A patent/ZA200300417B/xx unknown
- 2003-01-20 IS IS6692A patent/IS6692A/is unknown
- 2003-01-24 EC EC2003004448A patent/ECSP034448A/es unknown
- 2003-01-27 NO NO20030419A patent/NO20030419L/no not_active Application Discontinuation
-
2009
- 2009-05-29 US US12/475,096 patent/US20100029603A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL153934A (en) | 2007-07-24 |
| EP1307471A1 (en) | 2003-05-07 |
| IS6692A (is) | 2003-01-20 |
| ATE294812T1 (de) | 2005-05-15 |
| CN1444596A (zh) | 2003-09-24 |
| US20100029603A1 (en) | 2010-02-04 |
| SK882003A3 (en) | 2003-07-01 |
| JP2004505093A (ja) | 2004-02-19 |
| ES2241854T3 (es) | 2005-11-01 |
| BR0112791A (pt) | 2003-06-24 |
| MXPA03000845A (es) | 2004-04-05 |
| WO2002010188A1 (en) | 2002-02-07 |
| PL366235A1 (en) | 2005-01-24 |
| AU8201601A (en) | 2002-02-13 |
| US7696190B2 (en) | 2010-04-13 |
| KR20030029640A (ko) | 2003-04-14 |
| CZ2003270A3 (cs) | 2003-06-18 |
| HUP0301592A2 (hu) | 2003-09-29 |
| CN1220696C (zh) | 2005-09-28 |
| NO20030419D0 (no) | 2003-01-27 |
| AR029989A1 (es) | 2003-07-23 |
| PE20020331A1 (es) | 2002-04-30 |
| US20040043976A1 (en) | 2004-03-04 |
| DE60110606T2 (de) | 2005-12-01 |
| ECSP034448A (es) | 2003-03-10 |
| HRP20030060A2 (en) | 2004-06-30 |
| CA2416311C (en) | 2009-04-28 |
| DE60110606D1 (de) | 2005-06-09 |
| CA2416311A1 (en) | 2002-02-07 |
| EP1307471B1 (en) | 2005-05-04 |
| NO20030419L (no) | 2003-01-27 |
| AU2001282016B2 (en) | 2005-11-10 |
| ZA200300417B (en) | 2004-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL178864A0 (en) | 3'-prodrugs of 2'-deoxy-??-l-nucleosides | |
| AU5763101A (en) | Anti-inflammatory compounds and uses thereof | |
| IL159890A0 (en) | Dolastatin 10 derivatives | |
| HUP0401290A3 (en) | Low-lipoxygenase 1 barley | |
| SG89404A1 (en) | Resist composition | |
| IL153934A0 (en) | 16 alpha-methyl or ethyl substituted estrogens | |
| TW524063U (en) | Fasteners | |
| GB2361551B (en) | Reticle | |
| GB2364532B (en) | Composting toilet | |
| GB0020083D0 (en) | Assay 14 | |
| CA90058S (en) | Towel | |
| TW435611U (en) | Fasteners | |
| HK1052938A (en) | 16alpha-methyl or ethyl substituted estrogens | |
| GB0016080D0 (en) | Sequence 2 | |
| GB0018599D0 (en) | Sequence 4 | |
| GB0016082D0 (en) | Sequence 3 | |
| GB0101523D0 (en) | 20-Fluro-17(20)-Vinyl Steroids | |
| CA89683S (en) | Towel | |
| CA89994S (en) | Towel | |
| GB0025426D0 (en) | Coatings and compounds useful therefor | |
| GB0013197D0 (en) | Hygiene 2000 | |
| GB0126502D0 (en) | An infinity projecting door | |
| GB0020297D0 (en) | Navigator system-serves 2000 | |
| GB0000602D0 (en) | Overguard phase 2 | |
| GB0024993D0 (en) | 131 Paint system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |